The Epidemiology and Pathogenesis and Treatment of Pseudomonas aeruginosa Infections: An Update

D Reynolds, M Kollef - Drugs, 2021 - Springer
Pseudomonas aeruginosa is a Gram-negative bacterial pathogen that is a common cause of
nosocomial infections, particularly pneumonia, infection in immunocompromised hosts, and …

[HTML][HTML] Antibiotics in treatment of COVID-19 complications: a review of frequency, indications, and efficacy

M Chedid, R Waked, E Haddad, N Chetata… - Journal of infection and …, 2021 - Elsevier
Objectives To report available information in the literature regarding frequency, indications,
types of antibiotic usage, duration, and their efficacy in Covid-19 infected patients. Methods …

Multidrug-resistant bacteria and alternative methods to control them: an overview

R Vivas, AAT Barbosa, SS Dolabela… - Microbial Drug …, 2019 - liebertpub.com
Antibiotic resistance is one of the greatest challenges in the health system nowadays,
representing a serious problem for public health. Initially, antibiotic-resistant strains were …

Rationalizing antimicrobial therapy in the ICU: a narrative review

JF Timsit, M Bassetti, O Cremer, G Daikos… - Intensive care …, 2019 - Springer
The massive consumption of antibiotics in the ICU is responsible for substantial ecological
side effects that promote the dissemination of multidrug-resistant bacteria (MDRB) in this …

Antimicrobial resistance in the next 30 years, humankind, bugs and drugs: a visionary approach

M Bassetti, G Poulakou, E Ruppe, E Bouza… - Intensive care …, 2017 - Springer
Purpose To describe the current standards of care and major recent advances with regard to
antimicrobial resistance (AMR) and to give a prospective overview for the next 30 years in …

Recent approaches for downplaying antibiotic resistance: molecular mechanisms

S Ahmed, MZ Ahmed, S Rafique… - BioMed Research …, 2023 - Wiley Online Library
Antimicrobial resistance (AMR) is a ubiquitous public health menace. AMR emergence
causes complications in treating infections contributing to an upsurge in the mortality rate …

The lower respiratory tract microbiome of critically ill patients with COVID-19

P Gaibani, E Viciani, M Bartoletti, RE Lewis, T Tonetti… - Scientific reports, 2021 - nature.com
COVID-19 infection may predispose to secondary bacterial infection which is associated
with poor clinical outcome especially among critically ill patients. We aimed to characterize …

Comparative efficacy and safety of treatment options for MDR and XDR Acinetobacter baumannii infections: a systematic review and network meta-analysis

K Kengkla, K Kongpakwattana… - Journal of …, 2018 - academic.oup.com
Objectives To comprehensively compare and rank the efficacy and safety of available
treatment options for patients with MDR and XDR Acinetobacter baumannii (AB) infection …

[HTML][HTML] Control and management of multidrug resistant Acinetobacter baumannii: A review of the evidence and proposal of novel approaches

SE Weinberg, A Villedieu, N Bagdasarian… - Infection Prevention in …, 2020 - Elsevier
Hospital-acquired infections are on the rise and are a substantial cause of clinical and
financial burden for healthcare systems. While infection control plays a major role in …

Antibiotic resistance in patients with cystic fibrosis: past, present, and future

EP Perikleous, D Gkentzi, A Bertzouanis, E Paraskakis… - Antibiotics, 2023 - mdpi.com
Patients with cystic fibrosis (CF) are repeatedly exposed to antibiotics, especially during the
pulmonary exacerbations of the disease. However, the available therapeutic strategies are …